REC 603
Alternative Names: REC-603; Recombinant HPV 9-valent vaccine - Jiangsu Recbio TechnologyLatest Information Update: 12 Aug 2022
Price :
$50 *
At a glance
- Originator Jiangsu Recbio Technology
- Class Cancer vaccines; Papillomavirus vaccines; Synthetic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Cervical cancer; Condylomata acuminata